Viral infections affect several million patients annually.
Although
hundreds of viruses are known to be pathogenic, only a few can be
treated in the clinic with available antiviral drugs. Naturally based
pharmacotherapy may be a proper alternative for treating viral diseases.
Several natural and semisynthetic abietane-type diterpenoids have
shown important antiviral activities. In this study, a biological
evaluation of a number of either C-18- or C-19-functionalized known
semisynthetic abietanes against
Zika virus
,
Dengue virus
,
Herpes virus simplex
type
1, and
Chikungunya virus
are reported.
Semisynthetic abietane ferruginol and its analogue 18-(phthalimid-2-yl)ferruginol
displayed broad-spectrum antiviral properties. The scale-up synthesis
of this analogue has been optimized for further studies and development.
This molecule displayed an EC
50
between 5.0 and 10.0 μM
against Colombian Zika virus strains and EC
50
= 9.8 μM
against Chikungunya virus. Knowing that this ferruginol analogue is
also active against
Dengue virus type
2 (EC
50
= 1.4 μM, DENV-2), we can conclude that this compound is a
promising broad-spectrum antiviral agent paving the way for the development
of novel antivirals.